Equities Analysts Set Expectations for U.S. Physical Therapy, Inc.’s FY2019 Earnings (NYSE:USPH)

U.S. Physical Therapy, Inc. (NYSE:USPH) – Analysts at Jefferies Financial Group reduced their FY2019 earnings per share estimates for U.S. Physical Therapy in a report released on Tuesday, November 12th. Jefferies Financial Group analyst B. Tanquilut now expects that the company will earn $2.86 per share for the year, down from their prior forecast of $2.94. Jefferies Financial Group also issued estimates for U.S. Physical Therapy’s Q4 2019 earnings at $0.68 EPS and FY2020 earnings at $3.05 EPS.

Other analysts have also recently issued research reports about the stock. ValuEngine raised shares of U.S. Physical Therapy from a “hold” rating to a “buy” rating in a research report on Friday, November 1st. Zacks Investment Research reissued a “hold” rating on shares of U.S. Physical Therapy in a research report on Saturday, October 19th. Finally, Barrington Research raised shares of U.S. Physical Therapy from a “market perform” rating to an “outperform” rating and set a $130.00 price target on the stock in a research report on Friday, November 8th. One equities research analyst has rated the stock with a hold rating and three have given a buy rating to the stock. The company presently has a consensus rating of “Buy” and a consensus target price of $127.20.

Shares of USPH opened at $115.25 on Friday. The stock has a market capitalization of $1.49 billion, a PE ratio of 40.47, a P/E/G ratio of 3.33 and a beta of 1.09. U.S. Physical Therapy has a 1 year low of $98.69 and a 1 year high of $148.48. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.88 and a current ratio of 1.47. The company’s 50-day simple moving average is $133.19 and its 200-day simple moving average is $126.65.

U.S. Physical Therapy (NYSE:USPH) last issued its quarterly earnings results on Thursday, November 7th. The company reported $0.71 earnings per share (EPS) for the quarter, hitting the Thomson Reuters’ consensus estimate of $0.71. The business had revenue of $117.30 million for the quarter, compared to analysts’ expectations of $121.28 million. U.S. Physical Therapy had a net margin of 6.36% and a return on equity of 16.57%. The business’s quarterly revenue was up 3.7% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.64 earnings per share.

A number of large investors have recently modified their holdings of the stock. Mason Street Advisors LLC raised its holdings in U.S. Physical Therapy by 1.8% in the third quarter. Mason Street Advisors LLC now owns 4,337 shares of the company’s stock valued at $566,000 after acquiring an additional 77 shares in the last quarter. M&T Bank Corp raised its holdings in U.S. Physical Therapy by 2.9% in the second quarter. M&T Bank Corp now owns 3,153 shares of the company’s stock valued at $386,000 after acquiring an additional 90 shares in the last quarter. Louisiana State Employees Retirement System increased its stake in U.S. Physical Therapy by 2.1% in the second quarter. Louisiana State Employees Retirement System now owns 4,800 shares of the company’s stock valued at $616,000 after purchasing an additional 100 shares during the last quarter. Oregon Public Employees Retirement Fund increased its stake in U.S. Physical Therapy by 2.0% in the second quarter. Oregon Public Employees Retirement Fund now owns 5,013 shares of the company’s stock valued at $614,000 after purchasing an additional 100 shares during the last quarter. Finally, Conestoga Capital Advisors LLC increased its stake in U.S. Physical Therapy by 4.6% in the second quarter. Conestoga Capital Advisors LLC now owns 2,755 shares of the company’s stock valued at $338,000 after purchasing an additional 120 shares during the last quarter.

In other news, Director Harry S. Chapman bought 2,400 shares of U.S. Physical Therapy stock in a transaction that occurred on Monday, November 11th. The shares were purchased at an average price of $117.00 per share, with a total value of $280,800.00. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Christopher J. Reading sold 7,000 shares of the firm’s stock in a transaction that occurred on Monday, August 19th. The shares were sold at an average price of $135.13, for a total transaction of $945,910.00. The disclosure for this sale can be found here. 2.50% of the stock is owned by company insiders.

The company also recently announced a quarterly dividend, which will be paid on Friday, December 13th. Investors of record on Monday, November 18th will be issued a $0.30 dividend. The ex-dividend date of this dividend is Friday, November 15th. This represents a $1.20 annualized dividend and a yield of 1.04%. U.S. Physical Therapy’s dividend payout ratio (DPR) is 45.28%.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc, through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.

See Also: Quiet Period Expirations Explained

Earnings History and Estimates for U.S. Physical Therapy (NYSE:USPH)

Receive News & Ratings for U.S. Physical Therapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy and related companies with MarketBeat.com's FREE daily email newsletter.